Sentara Infusion Services 2023-02-22 Health serious FDA
Health · FDA · Recall #FDA-D-0302-2023
LEVOTHYROXINE 25MCG IN NS 1.25ML SYRINGE, Thyroid, Rx Only, Sentara Home Infusion… Recall
Issued February 22, 2023 · Sentara Infusion Services
In February 2023, Sentara Infusion Services recalled the LEVOTHYROXINE 25MCG IN NS 1.25ML SYRINGE, Thyroid, Rx Only, Sentara Home Infusion…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of sterility assurance
What you should do
- 1 Stop using LEVOTHYROXINE 25MCG IN NS 1.25ML SYRINGE, Thyroid, Rx Only, Sentara Home Infusion… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Sentara Infusion Services to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Sentara Infusion Services
- Category
- Health
- Recall date
- February 22, 2023
- Units affected
- Not reported
- Sold at
- Dispensed to Patients Nationwide.
- Recall number
- FDA-D-0302-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Sentara Infusion Services has 27 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.